We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MD icon
2326
Pediatrix Medical
MD
$2.2B
$516K ﹤0.01%
34,745
-208,170
-86% -$3.4M
CHEA
2327
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
$515K ﹤0.01%
49,998
CBAY
2328
DELISTED
Cymabay Therapeutics
CBAY
$513K ﹤0.01%
+81,780
New +$311K
WOW
2329
DELISTED
WideOpenWest
WOW
$510K ﹤0.01%
+56,015
New +$635K
DRAYW
2330
CALL
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$509K ﹤0.01%
50,000
RJAC
2331
DELISTED
Jackson Acquisition Company
RJAC
$507K ﹤0.01%
49,896
J icon
2332
Jacobs Solutions
J
$16B
$506K ﹤0.01%
+5,091
New +$500K
ITQRW
2333
CALL
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
$504K ﹤0.01%
49,997
HESM icon
2334
Hess Midstream
HESM
$5.19B
$504K ﹤0.01%
+16,855
New +$481K
AMPY icon
2335
Amplify Energy
AMPY
$158M
$503K ﹤0.01%
+57,222
New +$487K
VLATW
2336
CALL
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
$503K ﹤0.01%
49,995
LOKM.WS
2337
CALL
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$502K ﹤0.01%
49,996
TMCWW
2338
CALL
TMC The Metals Company Warrants
TMCWW
$474K
$501K ﹤0.01%
650,000
TRUE
2339
DELISTED
TrueCar
TRUE
$500K ﹤0.01%
+199,345
New +$415K
CLW icon
2340
Clearwater Paper
CLW
$348M
$500K ﹤0.01%
13,212
+3,999
+43% +$156K
YI
2341
111 Inc
YI
$31.3M
$499K ﹤0.01%
16,534
-3,646
-18% -$106K
SEPAW
2342
CALL
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$498K ﹤0.01%
50,000
VECO icon
2343
Veeco
VECO
$2.62B
$497K ﹤0.01%
+26,761
New +$503K
XLB icon
2344
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$497K ﹤0.01%
+12,800
New +$492K
KYCH
2345
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
$496K ﹤0.01%
49,100
LAMR icon
2346
Lamar Advertising Co
LAMR
$16.7B
$495K ﹤0.01%
+5,243
New +$485K
ITAQW
2347
CALL
DELISTED
Industrial Tech Acquisitions II, Inc. Warrants
ITAQW
$494K ﹤0.01%
48,524
-101,474
-68% -$5.32K
AIRC
2348
DELISTED
Apartment Income REIT Corp.
AIRC
$493K ﹤0.01%
+14,378
New +$527K
PL icon
2349
Planet Labs
PL
$6.94B
$492K ﹤0.01%
+113,160
New +$586K
BFLY.WS
2350
CALL
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$492K ﹤0.01%
200,000
-150,000
-43% -$76.7K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.